Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page's revision entry was updated from v3.5.3 to v3.5.4, replacing the previous revision tag. This reflects a minor update to the page's revision history rather than changes to core content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a website release/version change rather than a change to the displayed clinical trial information.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision: v3.5.2 replaces the previous Revision: v3.5.0 on the page.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No study data, eligibility criteria, or outcomes were altered.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.